Biotechnology Fund is a registered fund series of Rydex Series Funds (series S000003802). Net assets $135.1M as of 2026-03-31.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| AbbVie Inc. | ABBV | $10.0M | 739.47% |
| AbbVie Inc. | ABBV | $10.0M | 739.47% |
| AbbVie Inc. | — | $10.0M | 739.47% |
| AbbVie Inc. | ABBV | $10.0M | 739.47% |
| AbbVie Inc. | ABBV | $10.0M | 739.47% |
| Amgen Inc. | AMGN | $7.1M | 523.42% |
| Amgen Inc. | AMGN | $7.1M | 523.42% |
| Amgen Inc. | AMGN | $7.1M | 523.42% |
| Amgen Inc. | AMGN | $7.1M | 523.42% |
| Amgen Inc. | — | $7.1M | 523.42% |
| Gilead Sciences Inc. | GILD | $6.7M | 495.72% |
| Gilead Sciences Inc. | — | $6.7M | 495.72% |
| Gilead Sciences Inc. | GILD | $6.7M | 495.72% |
| Gilead Sciences Inc. | GILD | $6.7M | 495.72% |
| Gilead Sciences Inc. | GILD | $6.7M | 495.72% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $135.1M |
| 2025-12-31 | $109.0M |
| 2025-09-30 | $90.0M |
| 2025-06-30 | $82.7M |
| 2025-03-31 | $87.3M |
| 2024-12-31 | $91.7M |
| 2024-09-30 | $111.2M |
| 2024-06-30 | $109.3M |